Medical Equipment

Implantable Neurostimulation Devices Market Outlook 2025–2029: Emerging Opportunities and Key Drivers

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the implantable neurostimulation devices market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Implantable Neurostimulation Devices Market And What Value Is Projected For 2029?

The implantable neurostimulation devices market has expanded significantly in recent years. Its valuation is projected to increase from $5.02 billion in 2024 to $5.62 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.8%. Historically, this market expansion can be attributed to several factors, including a surging demand for non-pharmacological treatments, a rising preference for minimally invasive procedures, the growth of the geriatric population, an increase in the variety of psychiatric disorders, and the growing incidence of chronic diseases.

The implantable neurostimulation devices market is set for significant expansion in the coming years. It is projected to achieve a size of $8.86 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 12.1%. This projected growth is largely attributable to the escalating incidence of neurological conditions, an increase in lifestyle-related diseases, enhanced public understanding, a rise in spinal cord injuries, and increasing expenditures on healthcare. Noteworthy trends anticipated during this forecast period include the advancement of sensing technology, continuous innovations in neurostimulation technologies, the development of sophisticated products, the integration of closed-loop systems, and the adoption of wireless technology.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19520&type=smp

What Factors Are Boosting The Implantable Neurostimulation Devices Market?

The increasing occurrence of neurological conditions is anticipated to boost the expansion of the implantable neurostimulation device market in the future. These disorders are defined as conditions impacting the nervous system’s structure or function, leading to symptoms like paralysis, seizures, and difficulties with cognition. Greater exposure to risk factors including elevated blood pressure, congenital defects, or physical trauma contributes to an increase in diagnosed neurological disorders. Implantable neurostimulation devices are employed in the treatment of neurological disorders to modify nerve activity and reduce symptoms, especially when alternative therapies prove inadequate or unsuccessful. For example, data from 2024 by the Alzheimer’s Association, a US non-profit health organization, indicates that approximately 6.9 million Americans aged 65 and above are affected by Alzheimer’s disease, with 73% of this group being 75 or older. This figure is projected to climb to 12.7 million by 2050. Consequently, the growing incidence of neurological conditions will stimulate the implantable neurostimulation device market.

What Are The Core Segmentation Criteria In The Implantable Neurostimulation Devices Market?

The implantable neurostimulation devicesmarket covered in this report is segmented –

1) By Type: Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Other Types

2) By Application: Pain Management, Parkinson’s Disease, Urinary And Fecal Incontinence, Epilepsy, Gastroparesis, Other Applications

3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers

Subsegments:

1) By Spinal Cord Stimulation (SCS): Rechargeable SCS Devices, Non-Rechargeable SCS Devices

2) By Gastric Electric Stimulation (GES): Implantable Gastric Stimulators, Adjustable Gastric Stimulators

3) By Deep Brain Stimulation (DBS): DBS Devices for Movement Disorders, DBS Devices for Psychiatric Disorders

4) By Sacral Nerve Stimulation (SNS): SNS Devices for Urinary Incontinence, SNS Devices for Fecal Incontinence

5) By Vagus Nerve Stimulation (VNS): VNS Devices for Epilepsy, VNS Devices for Depression

6) By Other Types: Peripheral Nerve Stimulation (PNS), Cortical Stimulation Devices, Novel Neurostimulation Technologies

What Strategic Shifts And Innovations Are Influencing The Implantable Neurostimulation Devices Market?

Leading companies in the implantable neurostimulation devices market are prioritizing the development of sophisticated products, such as spinal cord stimulation (SCS) systems, aimed at alleviating chronic pain conditions. A spinal cord stimulation (SCS) system functions as a medical device that employs electrical impulses to modulate nerve activity in the spinal cord, thereby reducing chronic pain and improving patient quality of life when other therapies are insufficient. For example, in December 2022, Abbott, a US-based medical device company, announced the U.S. Food and Drug Administration (FDA) approval for its Eterna spinal cord stimulation (SCS) system. The Eterna SCS stands as the market’s smallest implantable, rechargeable spinal cord stimulator, specifically engineered for optimal daily comfort. It integrates Abbott’s proprietary BurstDR stimulation technology, which emulates natural brain firing patterns for excellent pain relief and is preferred by 87% of patients compared to traditional tingling stimulation. Requiring the fewest recharges, as few as five annually due to its Xtend energy technology, Eterna provides enhanced convenience. It also accommodates full-body MRI scans with TotalScan technology and is designed to adapt to future advancements without needing replacement. Abbott’s mobile application integration further allows for real-time tracking of battery life and charging status on iPhone devices.

Which Players Are Shaping The Competitive Landscape Of The Implantable Neurostimulation DevicesXX Market?

Major companies operating in the implantable neurostimulation devices market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Dignity Health, St. Jude Medical LLC, LivaNova PLC, Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., CURE Epilepsy, Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Pain Management NYC, Curonix LLC

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/implantable-neurostimulation-devices-global-market-report

What Regional Trends Are Shaping Growth In The Implantable Neurostimulation Devices Market?

North America was the largest region in the implantable neurostimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=19520&type=smp

Browse Through More Reports Similar to the Global Implantable Neurostimulation Devices Market 2025, By The Business Research Company

Neurostimulation Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report

Implantable Biomaterials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-biomaterials-global-market-report

Implantable Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795